| ²é¿´: 256 | »Ø¸´: 0 | ||
zyx510½ð³æ (СÓÐÃûÆø)
|
[ÇóÖú]
ÇóÎÄÏ×
|
|
1. Hussain AR, Ahmed M, Ahmed SO, et a1£® Proteasome inhibitor MG-132 mediated expression of p27Kip1 via S-phase kinase protein degradation induces cell cycle coupled apoptosis in primary effusion lymphoma cells. Leuk Lymphoma, 2009, Jul;50(7):1204-1213. 2. Ying WZ, Zhang HG, Sanders PW. EGF receptor activity modulates apoptosis induced by inhibition of the proteasome of vascular smooth muscle cells. J Am Soc Nephrol, 2007,18:131¨C142. 3. Kapadia MR, Eng JW, Jiang Q, et a1. Nitric oxide regulates the 26S proteasome in vascular smooth muscle cells. Nitric Oxide, 2009, 20: 279¨C288. 4. Zhang F, Laiho M. On and off: proteasome and TGF-beta signaling. Exp Cell Res, 2003, 291:275¨C281. 5. Meiners S, Hocher B,Weller A, et al. Downregulation of matrix metalloproteinases and collagens and suppression of cardiac fibrosis by inhibition of the proteasome. Hypertension, 2004, 44:471¨C477. 6. Herrmann J, Lerman LO, Mukhopadhyay D, et a1. Angiogenesis in atherogenesis. Arterioscler Thromb Vasc Biol, 2006, 26:1948¨C1957. |
» ²ÂÄãϲ»¶
Ë®Äý½ºÎ¢Õë
ÒѾÓÐ0È˻ظ´
Çóµ÷¼Á£¬»ù´¡Ò½Ñ§Àà¶¼¿ÉÒÔ£¬Ó¢ÓïÒѹýÁù¼¶£¬ÓпÆÑоÀú
ÒѾÓÐ0È˻ظ´
Ô¤·ÀҽѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ275È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ0È˻ظ´
305ÁÙ´²Ò½Ñ§£¬Çóµ÷¼Á
ÒѾÓÐ0È˻ظ´
ÖÐɽ´óѧ¡°ÉúÎïҽѧ´«¸Ð¼ì²â¼°Î¢Á÷¿Ø¼¼Êõ¡°ÍŶÓÕв©Ê¿Éú -ÉîÛÚ¹âÃ÷
ÒѾÓÐ6È˻ظ´
¹ú¼ÒÄÉÃ׿ÆÑ§ÖÐÐÄÕÐÊÕ2026ÄêÖйú-µ¤ÂóÁªºÏÅàÑø²©Ê¿Ñо¿Éú
ÒѾÓÐ0È˻ظ´
¿¼Ñе÷¼Á
ÒѾÓÐ4È˻ظ´
¹ú¼ÒÄÉÃ׿ÆÑ§ÖÐÐÄÑо¿×éÏÖÕÐÊÕ²©Ê¿Ñо¿ÉúºÍÏîĿƸÓÃÑо¿ÖúÀí
ÒѾÓÐ0È˻ظ´
¹ú¼ÒÄÉÃ׿ÆÑ§ÖÐÐÄÕÐÊÕÖйú-µ¤ÂóÁªºÏÅàÑø²©Ê¿Ñо¿ÉúÏîÄ¿£¨Sino-Danish College£©
ÒѾÓÐ0È˻ظ´














»Ø¸´´ËÂ¥